Niagen Bioscience, Inc. — Director's Dealing 2012

Jun 21, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2012-06-20

Reporting Person: Brauser Michael (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-20	Common Stock	P	83498	$0.65	Acquired	2099212	Direct

Footnotes

F1: Excludes 153,846 shares acquired by Mr. Brauser's two adult sons. Funds for such purchases were loaned by Birch Tree Capital, LLC, to the purchasers, of which Mr. Brauser is the managing member. Mr. Brauser disclaims beneficial ownership of such shares.